Remdesivir Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for IV & Injection
Available Strengths: Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)
Reference Brands: Veklury® (EU & US)
Category: Anti Covid Medicines
Remdesivir 100 mg lyophilised powder and 100 mg/20 mL concentrate for intravenous infusion, an antiviral for COVID-19. For hospitals, tender suppliers and licensed importers in markets where the licence and registration position allows supply.
Manufacture or export Remdesivir? List it or send an offer →
Product Description:
Remdesivir is a nucleotide analogue prodrug. Inside cells it becomes an active triphosphate that the SARS-CoV-2 RNA polymerase takes up in place of a natural building block, which halts viral RNA synthesis. Poor oral bioavailability means it is given only intravenously. This page lists a 100 mg vial of lyophilised powder, reconstituted with sterile water and diluted in sodium chloride 0.9%, and a 100 mg/20 mL (5 mg/mL) concentrate that only needs dilution. The powder is more common because it needs no refrigeration.
Remdesivir is approved for COVID-19 in hospitalised adults and children, particularly those with pneumonia needing oxygen, and as a three-day course for high-risk patients not needing oxygen. Adults usually receive 200 mg on day one, then 100 mg once daily, each infused over 30 to 120 minutes. Liver function and prothrombin time are checked before and during treatment. Infusion and hypersensitivity reactions can occur, so patients are observed. Chloroquine and hydroxychloroquine are avoided because they can reduce its antiviral activity.
Sourcing notes. Remdesivir remains under patent in many countries, and some generic versions may be sold only in territories covered by voluntary licences, so confirm the licence and patent position for your market first. It is a prescription-only hospital medicine needing registration, emergency authorisation, or a tender or named-patient route. Store the powder below 30 °C and the concentrate at 2-8 °C, as labelled. Ask for the CTD or ACTD dossier, Zone IVb stability data, a certificate of analysis for each batch, GMP certificate and CoPP.
Remdesivir — third party manufacturing & bulk supply
Remdesivir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Remdesivir is supplied as Lyophilized powder for IV & Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Remdesivir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Remdesivir →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Several Indian manufacturers make remdesivir under Gilead's 2020 licences, though not all of them still produce it regularly. We match your enquiry with licensed makers that can supply your market and confirm current availability and documents.
No. The Gilead licences allow sale in a defined list of 127 countries, mostly low- and middle-income. For a market outside that list, patent and registration status must be checked first.
100 mg per vial, mainly as a lyophilised powder for reconstitution and dilution. A 100 mg/20 mL (5 mg/mL) solution was also approved in the US but is no longer in the current US label.
Under the US label, the lyophilised powder is stored below 30 °C; the older solution concentrate needed 2 to 8 °C. Storage statements differ between countries and products, so follow the labelling of the product you buy.
Related Products
Favipiravir Tablet
Strength:
200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Avigan
View DetailsTocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View DetailsNirmatrelvir / Ritonavir Tablet
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View DetailsBaricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit